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In all provinces in South Africa specialist medical services 
are under threat. Many of these services are perceived as 
being expensive and serving patients with limited outcomes. 
Resource constraints (in particular nursing shortages and 
budgetary limitations) have forced specialists to examine their 
practices and curtail those practices that offer low yield at high 
financial cost. The recently published ‘head injury’ protocols 
are a good example of such a relook.1 Denying ventilatory 
support to premature infants weighing less than 900 g is 
another example of a policy designed to reassign resources to 
those who might achieve a better outcome. 
All cardiac surgical units within the State sector in South 
Africa are affected by these resource constraints. The long 
waiting lists for surgery are the most obvious manifestation of 
these limitations. For children with congenital heart disease, a 
longer waiting period may mean the difference between low-
risk and high-risk (and more expensive) surgery. At worst, the 
wait may make safe surgery impossible. 
Prioritising patients within waiting lists is not an easy task. 
We have some experience with at least three approaches to 
shortening lists: 
1. Increasing resources (even for a short period of time, as 
happened during 2000 in the Western Cape) helps to shorten 
the list. ‘Fairness’ can be achieved within a hospital setting by 
rotation of priorities – cardiac patients this year, tonsillectomy 
patients next year and so on. 
2. The use of more expensive devices may allow non-surgical 
treatment of simpler lesions in the catheterisation laboratories 
rather than in the operating theatre. (While the cost of closing 
an atrial septal defect with a closure device may exceed the cost 
of the same procedure surgically in the setting of a developing 
country,2 the opening of an operating space for a child with 
tetralogy of Fallot may offset that extra cost, in terms of future 
hospitalisations and morbidity).
3. Careful reorganisation of the list, which involves a 
thorough re-analysis of the indications for surgery and 
postulated outcome for each patient. It may require the 
wisdom of Solomon to deny surgery to patients who are 
perceived as benefiting less from surgery than others. 
With our profession’s basic commitment to preserve life for 
all who seek our help, selecting any patients who will not be 
helped is an ethical minefield. The only criterion that stands 
even a chance of being a ‘fair’ or ‘just’ basis for selection is the 
likelihood of long-term medical benefit from the care provided. 
There is no ethical ground for choosing on the grounds of long-
term contribution to society or any other assessment of ‘worth’. 
But how do we assess the likelihood of long-term medical 
benefit? Personal moral judgements (of social worth and 
promise) inevitably cloud assessments of medical benefit. This 
seems at least in part to be the problem with certain patients 
being refused cardiac surgery.
The ‘Baby Ronnie’ episode brought the (sincere) attempts of 
one province to shorten the waiting list of children waiting for 
cardiac surgery into the limelight. Baby Ronnie was flown at 
great cost to a private facility in the Cape when he was denied 
cardiac surgery in the State sector in another province.3
What made Baby Ronnie different from any other child with 
the same congenital heart defect? He was born with Down 
syndrome.
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About 1 in 1 000 children has Down syndrome. Extra 
chromosomal material results in a myriad of potential 
problems for the affected individual. About 40% of Down 
syndrome children will have cardiac abnormalities, ranging 
from the simple arterial duct to the complex atrioventricular 
septal defect. Virtually all these defects are amenable to 
surgical correction and extended survival is possible. In South 
Africa many of these children do not undergo cardiac surgery. 
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The scope of the problem of children 
with Down syndrome and congenital 
heart defects
About 1 in 1 000 children has Down syndrome (most 
commonly due to trisomy 21).4 The extra chromosomal 
material results in a myriad of potential problems for the 
affected individual. About 40% of Down syndrome children 
will have cardiac abnormalities ranging from the simple 
arterial duct to the atrioventricular septal defect.5 Virtually 
all defects are amenable to surgical correction and extended 
survival is possible. 
The majority of children with Down syndrome and 
congenital heart defects (60%) will have simpler defects such as 
ventricular septal defects, tetralogy of Fallot or patent arterial 
ducts. In our opinion there are no medical reasons that make 
Down syndrome patients with these particular defects less 
likely to benefit from surgery than their counterparts with a 
normal karyotype. 
The other 40% of patients with Down syndrome and a heart 
abnormality will have an atrioventricular septal defect, which 
is a far more complex lesion.  This abnormality in essence 
involves the presence of a large gap in the walls between 
both atria and ventricles and abnormal atrioventricular 
valves. (These patients have a common atrioventricular valve 
instead of true ‘mitral’ and ‘tricuspid’ valves.6) Repair of the 
atrioventricular defect is a significant challenge for the surgeon.
 If repair of atrioventricular septal defects is delayed beyond 
the first year of life, irreversible pulmonary vascular changes 
may ensue as a consequence of the high-pressure left to right 
shunt. Surgery may then no longer be possible.7 After the 
first year of life, if they survive congestive cardiac failure 
and repeated chest infections, unoperated children enter a 
‘honeymoon period’ as they develop irreversible pulmonary 
hypertension. They then succumb in their third decade from 
right heart failure or the consequences of persistent cyanosis.
Patients with Down syndrome also have other associated 
abnormalities such as mid-face hypoplasia and airway 
obstruction that increase their propensity to develop 
accelerated pulmonary hypertension.8 For these reasons, 
there is a perception that cardiac surgery in these patients is 
more hazardous and associated with a higher morbidity and 
mortality. This perception is incorrect.
Reasons given for not operating on 
Down syndrome children with an 
atrioventricular septal defect
Poor surgical results
In an article published in the early 1980s Bull and colleagues9 
argued that not offering surgery to Down syndrome patients 
with an atrioventricular septal defect resulted in equivalent 
survival to the surgical option. Despite cogent arguments, their 
ideas were highly controversial at the time. The article was 
published in The Lancet after having been rejected by the New 
England Journal of Medicine.10
Improvements in surgical outcome have resulted in their 
conclusions becoming obsolete. The life expectancy of patients 
with Down syndrome has doubled since the 1970s largely as 
a consequence of treatment of these heart lesions.11 Most USA 
and UK centres would claim 30-day mortality figures of less 
than 5% for correction of an atrioventricular septal defect in a 
patient with Down syndrome.12
There is no reason why South African surgical centres 
cannot achieve equivalent surgical results (Table I).  At Red 
Cross Children’s Hospital, the mortality for isolated complete 
atrioventricular canal repair was 6.9% (4 of 58, of whom 44 had 
Down syndrome).13 
Limited lifespan and early dementia of patients 
with Down syndrome
The lifespan of a person with Down syndrome is less than 
that of a person with a normal karyotype.11 Nevertheless, the 
patient may reach an advanced age. In societies with resources, 
13% of patients with Down syndrome reach the age of 60 
years.14 
Intellectual handicap is universal in individuals with Down 
syndrome and most children will face institutionalisation as 
adults. Up to 50% of patients with Down syndrome will show 
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Table I. Five years’ experience at Red Cross Children’s Hospital, comparing selected procedures with Stark et al.*
              Red Cross: 1 unit, 5 years    UK: 5 units, 1 year
Operation  Number   Mortality (%)  Number   Mortality (%)
All operations  1 334   5.1   1 378   4.0
Isolated VSD     162   1.2      168   0.6
Fallot’s tetralogy     115   3.5        88   2.3
Switch (simple TGA)     15   6.7        67   0
Complete AVSD      58   7        55   3.6
*Reproduced from: Hewitson et al.13  
VSD = ventricular septial defect; TGA = transposition of the great arteries; AVSD = atrioventricular septal defect.
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signs of Alzheimer’s disease by the age of 50.15 Recent data 
suggest that the diagnosis of dementia in these individuals is 
difficult and late-onset hypothyroidism as well as depression 
as a consequence of the death of a caregiver may cause a 
‘pseudodementia’.16
For some, sheltered employment will be possible. For 
all affected individuals, however, the intangible elements 
that make up ‘quality of life’ will nevertheless be present in 
abundance.17
Does not fixing a cardiac defect save money?
The patient with a significant defect is likely to suffer from 
cardiac failure and repeated chest infections. The ‘honeymoon’ 
period alluded to previously may take a year to develop 
with symptoms and signs of congestion gradually decreasing 
unless the patient succumbs prior to this time. Each episode of 
pneumonia might result in a hospital admission. Each illness 
may be associated with time away from work for the child’s 
parents. The cost of an admission to hospital may rapidly start 
to offset money saved by not repairing a defect (see article by 
Roussot et al.18 in this edition of the journal). 
The patient with severe pulmonary hypertension is said to be 
relatively free from symptoms until the 2nd or 3rd decade.9 The 
end of their lives is associated with worsening dyspnoea and 
cyanosis and life-threatening dysrhythmias; in our experience, 
the last few years of these adolescent children’s lives are often 
miserable.  
How many Down syndrome patients 
are there?
Only 8% of patients with congenital heart disease have Down 
syndrome (i.e. on the average surgical waiting list only 8 of 
every 100 patients should have Down syndrome).  Therefore 
not performing surgery on these patients will represent only 
an 8% decrease in waiting lists. (If simpler lesions are corrected 
and atrioventricular septal defects are not, a ‘saving’ of 3 - 4% 
on a list will be achieved.) 
What are the rights of patients with 
Down syndrome?
The rights to basic health care are guaranteed to all South 
Africans as a constitutional right.19 The definition of what 
constitutes ‘basic health care’ is open to interpretation. In South 
African law, the Soobramoney case is cited as a legal definition 
of basic health care and has been used to justify withholding 
super specialist services.20 
It could be argued that an expensive operation that 
‘guarantees’ a long survival is also effective and basic health 
care when the costs are defrayed over a long time period. For 
example, the chances of surviving for more than 30 years after 
repair of tetralogy of Fallot are excellent.21
The challenge to health care planners is not only to make 
sure that no one succumbs from a simple pneumonia but also 
to ensure that the patient with congenital heart disease from 
Mafikeng has a similar chance to the patient from Cape Town 
to receive the surgery that will extend his/her life. The patients 
who benefit from so-called ‘ivory tower’ medicine do not 
come from a different country to the patient who dies when 
gastroenteritis is not treated properly.  
Is it unethical not to offer surgery to 
South African patients with Down 
syndrome?
Distribution of medical care on the basis of lifespan, quality 
of life, or contribution to society is a slippery slope towards 
denying care to many other patients, such as severe burns or 
oncology patients to mention only two. Why should Down 
syndrome be singled out?
In an elegant article in the British Medical Journal, Savulescu22 
argues that medical practitioners are used to rationing 
resources. Furthermore, limiting available treatments with 
some benefit in favour of treatments benefiting more people 
to a greater degree may not be illegal despite being unethical, 
provided decisions taken to limit medical care are taken in 
consensus and that the process is transparent. In addition, 
the decision to limit access to a particular resource should be 
considered for reversal should circumstances change. 
The reasons for not offering surgery to children with Down 
syndrome and congenital heart defects – never working, 
intellectual impairment, and the ‘stealing’ of surgery from 
potentially productive individuals – need to be carefully 
examined. In a country with 30% unemployment, ‘not being 
employable in the open market’ is a somewhat soft reason to 
deny surgery. In addition, the right of mentally handicapped 
individuals to work is protected under basic labour laws!23
When we reject a child’s candidacy for surgery because he 
has a low IQ, then we have allowed judgements of social worth 
and promise to masquerade as questions of the likelihood of 
long-term medical benefits. 
It is disconcerting that within major urban centres there are 
units in the public sector hospitals which feel that they are not 
able to offer surgery to patients with atrioventricular septal 
defects and Down syndrome existing cheek-by-jowl with 
centres in the private sector where such children are offered 
surgery because they have parents with sufficient financial 
resources. 
Conclusion
The history of the South African medical establishment is 
tainted by less than perfect decisions taken for political and/
or financial expediency. The decision to restrict a service or 
withhold a particular service must be taken against a backdrop 
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of idealism and striving to obtain the maximum good rather 
than as a reaction to political or economic pressure. In the 
‘supermarket’ of medicine, super-specialists are the ‘loss 
leaders’. They enhance the quality of the entire system and this 
benefits not the health economist but the patient.  
Given scarcity of resources and in the face of the need to 
make tragic choices about how to deal with long waiting lists, 
what can we do? The first thing is to be truthful: acknowledge 
the limits and scarcities we face to both our patients and the 
public. There is a reticence to speak openly in the media about 
the health services in crisis because it puts health politicians in 
a bad light. But public money is being spent on a public service 
about which we must be transparent. Such transparency 
implies a readiness to admit that there are limits to what we 
can do, but also that we will not turn our backs on basic patient 
rights. 
The problems that beset South African cardiac surgery 
(which can be summarised as ‘too few operations for too 
many patients with too few nurses’) may in our opinion be 
better dealt with by reviewing our practices as a whole rather 
than denying surgery to one group of children with an easily 
identifiable genetic abnormality. 
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